CG34 Hypertension - costing report

A costing report and costing template have been produced by NICE to provide an implementation tool to estimate the financial impact to the NHS of implementing the NICE guideline CG34 'The management of hypertension in adults in primary care (partial update)' in England.

The costing report focuses on the financial impact of the key factors in this guideline update for England. The report has been prepared in consultation with the guideline development group and has been approved for publication by the Institute. It should be noted that the cost and activity assessments in the report are estimates based on a number of assumptions. These assessments provide an indication of the likely impact of the principal recommendations and are not absolute figures.

As part of this work, a costing template has been developed to provide health communities with the ability to assess the likely local impact of the principal recommendations in the appraisal based on their population. Other assumptions can be altered to better reflect local circumstances.

The Institute would welcome feedback from users to inform the development of future templates. Please email your comments to costing@nice.org.uk